Barecetamab, CAS 2275727-74-5

Product Description: Barecetamab (ISU-104) is a fully human anti-ErbB3 monoclonal antibody. Barecetamab can be used for the research of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Kim SB, et, al. 887P Final results and biomarker analysis from a phase I dose-expansion (part II) study of ISU104 (barecetamab; a novel anti-ErbB3) monotherapy or in combination with cetuximab (CET), in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). VOLUME 32, SUPPLEMENT 5, S797, SEPTEMBER 01, 2021.

CAS Number: 2275727-74-5

Molecular Weight: N/A

Compound Purity: 97.96

Research Area: Cancer

Solubility: H2O

Target: EGFR

• SKU: MEXHY-P99461-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99461-1
• Package Unit: 1 mg
• Quantity Unit: STK
• Conjugate: Unconjugated